Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Strand, Vibeke [1 ]
Mease, Philip J. [2 ,3 ]
McInnes, Iain B. [4 ]
Nash, Peter [5 ]
Thom, Howard [6 ]
Hunger, Matthias [7 ]
Gandhi, Kunal [8 ]
Mpofu, Shephard [9 ]
Jugl, Steffen [9 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[6] Univ Bristol, Bristol, Avon, England
[7] MAPI Grp, Munich, Germany
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1729
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
    Signorovitch, James E.
    Sikirica, Vanja
    Erder, M. Haim
    Xie, Jipan
    Lu, Mei
    Hodgkins, Paul S.
    Betts, Keith A.
    Wu, Eric Q.
    VALUE IN HEALTH, 2012, 15 (06) : 940 - 947
  • [42] Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn's disease: a matching-adjusted indirect comparison
    Ma, C.
    Dubinsky, M. C.
    Axelrad, J.
    Anyanwu, S.
    Tran, J.
    Lacerda, A.
    Joshi, N.
    Griffith, J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1866 - I1867
  • [43] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel H.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher W.
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 1913 - 1923
  • [44] Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison
    Bhak, Rachel Y.
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BLOOD, 2020, 136
  • [45] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 190 - 190
  • [46] Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn's disease: a matching-adjusted indirect comparison
    Thin, Lena
    Ma, Christopher
    Dubinsky, Marla
    Axelrad, Jordan
    Anyanwu, Samuel
    Tran, Jacinda
    Lacerda, Ana
    Joshi, Namita
    Griffith, Jenny
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 156 - 157
  • [47] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Edwards, Christopher J.
    Sawant, Ruta
    Garg, Vishvas
    Du, Ella X.
    Friedman, Alan
    Betts, Keith A.
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 167 - 181
  • [48] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Christopher J. Edwards
    Ruta Sawant
    Vishvas Garg
    Ella X. Du
    Alan Friedman
    Keith A. Betts
    Rheumatology and Therapy, 2021, 8 : 167 - 181
  • [49] Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter
    Strand, Vibeke
    Nash, Peter
    Thom, Howard
    Karabis, Andreas
    Gandhi, Kunal
    Porter, Brian
    Jugl, Steffen
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 914 - 915
  • [50] A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFGARTIGIMOD VERSUS RAVULIZUMAB FOR GENERALIZED MYASTHENIA GRAVIS
    Celico, L.
    Spaepen, E.
    De Francesco, M.
    Chiroli, S.
    Iannazzo, S.
    Ruck, T.
    Meuth, S. G.
    VALUE IN HEALTH, 2022, 25 (12) : S20 - S20
12345